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1ABSTRACT
Orchestration of immune function through STIM1-modulated 
calcium signaling in murine microglia
Hye Min Lim
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Joo Young Kim)
It is well established that the differentiation of microglia into active immune 
cells is governed by increase of sustained intracellular Ca2+ concentration ([Ca2+]i) 
in the cytoplasm, which is maintained by SOCE (store-operated calcium entry). 
Acute movements of immune cells are also controlled by Ca2+ signaling, especially 
by changes in the Ca2+ concentration within micro-domains ([Ca2+]micro-domains) at the 
cell periphery. The role of STIM1 in chronic and global [Ca2+]i changes, which 
governs the proliferation, gene expression and differentiation into active immune 
cells, has been well examined. However, the role of STIM1 in regulating peripheral 
[Ca2+]micro-domains in immune cells, including microglia, has not been studied yet. In 
this study, we found that murine Stim1-/- microglia showed severe defects in their 
acute movements, including purinergic stimulation-induced phagocytosis and 
chemotaxis, which is controlled by Ca2+ signaling in [Ca2+]micro-domains. Interestingly, 
Stim1-/- microglia exhibited highly fluctuating local [Ca2+]micro-domains changes at the 
cell periphery, and these fluctuations disappeared completely once mitochondrial 
membrane potential disruptors were added. Stim1-/- microglia also show attenuated
movements of Oria1 upon amoeboid shape-change induced by LPS, which seems to 
2be related to the partial reduction in [Ca2+]micro-domains fluctuations achieved by SOCE 
inhibitors. Our new discovery indicates that STIM1 is a critical controller of the 
local [Ca2+]micro-domains, not only through its regulation of SOCE pores, but also 
through its coordination of mitochondrial Ca2+ buffering capacity in micro-domains
of the cell periphery
In conclusion, STIM1 is a fundamental regulator of the Ca2+ signaling that is 
required for proper immune functioning of microglia. In that process, in addition to 
regulating sustained [Ca2+]i changes, STIM1 also controls [Ca2+]micro-domains changes 
through coordinating mitochondrial Ca2+ buffering capacity via local SOCE pores.
Key words: Microglia, STIM1, SOCE, immune function, global [Ca2+]i, 
local [Ca2+]micro-domains, Mitochondria
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I. INTRODUCTION
As an intracellular signaling molecule, cytoplasmic Ca2+ is one of the most 
widespread and versatile. An increment in cytoplasmic Ca2+ levels triggers many 
processes, and supports various actions of immune cells.1,2 Cytoplasmic Ca2+
increases following Ca2+ release from intracellular organelles and from Ca2+ influx 
across the plasma membrane.3 Ca2+ signaling is essential for microglial function, 
however this has not been completely investigated.4 Ca2+ influx through store-
operated calcium entry (SOCE), mediates sustained Ca2+ increase during the 
activation of immune functions in microglia.5,6 The concept of SOCE was first 
suggested by James Putney’s ‘capacitative Ca2+ entry’ hypothesis.7
The discovery of two central molecular components of SOCE, STIM1 and 
ORAI1, has allowed genetic and molecular manipulation of the SOCE pathway.8
The internal Ca2+ store has a limited capacity, and Ca2+ release from internal stores
is transient. So, Ca2+ entry from the extracellular environment following an initial 
transient Ca2+ release, is an indispensable process for many cellular functions.9
4STIM1 and STIM2 have been identified over the past few years. Together, they 
constitute the only known protein family that function simultaneously as internal
Ca2+ storage sensors, and as regulators of Ca2+ influx from the extracellular 
environment. STIM1 is a Type 1, single-spanning transmembrane protein 
containing an EF-hand Ca2+-binding motif, which functions as a sensor of Ca2+
levels in the lumen of the endoplasmic reticulum (ER). Depletion of ER-luminal 
Ca2+ stores induces a conformational change in STIM1. Binding of the C-terminal 
transmembrane domain of STIM1 activates the plasma membrane store-operated 
channel leading to Ca2+ influx.2,10-14 STIM2 is a homolog of STIM1, and it shares 
many features. It is reported that STIM2 contains an EF hand Ca2+-binding motif
with a lower affinity for Ca2+ than that of STIM1, and that it maintains basal Ca2+
concentration in various cells.5,15 ORAI1 has four transmembrane domains (TM1–
TM4) in the plasma membrane. Both its N-terminus and C-terminus face into the 
cytoplasm. ORAI1 is a selective, Ca2+ channel used to elevate cytosolic Ca2+ levels 
rapidly.2,3 ORAI1, also known as CRAC (Ca2+ release-activated Ca2+ Channel), is
fundamental to immune cell functioning and it has a vital role in the normal 
physiology of many other cell types.5,6,8,16-22
Microglia are specialized macrophages found in the central nervous system 
(CNS). They are of hematopoietic origin, acting as primary responding cells during
infection and tissue injury.23-26 Lipopolysaccharide (LPS), which is an agonist of 
Toll-like receptor 4 (TLR4), is widely used to enhance microglial activation and to 
accelerate several morphological changes. These include phagocytosis and secretion 
of pro-inflammatory mediators,18,23,27-31 which are both dependent on a sustained 
increase in the intracellular Ca2+ concentration ([Ca2+]i).23,28 LPS also induces a shift 
in the microglial gene expression profile, which is mainly mediated by the NFAT 
transcription factor.32 LPS-stimulation leads to a chronic elevation of basal [Ca2+]i
along with a suppression of receptor-evoked calcium signaling.28 Microglia
activated by LPS have increased levels of cytokine secretion; such as TNF-α and 
IL-6, and show enhanced phagocytic activity.18 Both UDP-mediated phagocytosis33
and ATP-induced chemotaxis41 are regulated primarily by the local [Ca2+] in focal 
5micro-domains ([Ca2+]micro-domains) found at the edge of cells, near the phagosome or 
focal adhesion spot, for example.34,35,36
Meanwhile, there is now a growing awareness that ‘local Ca2+ signals’ or 
‘Ca2+ micro-domains’, can be generated by opening Ca2+ channels.37-39 The most 
fundamental local Ca2+ signal is the Ca2+ micro-domains that develops rapidly next
to open plasmalemmal Ca2+ channels; such as voltage-gated L-type (Cav1.2) and 
SOCE. Ca2+ micro-domains arising from these channels are remarkably versatile in 
triggering a range of responses that differ enormously in both temporal and spatial
profile.39 It has been anticipated that a regulatory relationship might exist between
mitochondria the controlled SOCE of STIM1, since mitochondria can buffer Ca2+
within micro-domains by taking up Ca2+ via mitochondrial Ca2+ uniporters working 
at high [Ca2+].40-42 The positioning of mitochondria close to ORAI1 channel clusters 
was reported,40 and Ca2+ buffering by mitochondria was involved in sustaining Ca2+
influx through ORAI1 by attenuating the Ca2+-sensitive inactivation of ORA1. On 
the other hand, Stim1-/- mouse embryonic fibroblasts (MEF) showed elongated 
mitochondria for unknown reason,43 and mitofusin-2, one of the proteins found on 
mitochondria that tethers to ER membranes, was required for the mitochondrial 
membrane potential to exert an effect on the magnitude of SOCE influx.44 However, 
the suspected relationship between mitochondria and the controlled SOCE of 
STIM1 has been neglected since the discovery of the effect of mitofusin-2 on SOCE.
Indeed, the working machinery regulating micro-domains Ca2+ levels remains
completely unrevealed. In this study, we serendipitously discovered retarded 
motions of ORAI1, remaining at the cell periphery of LPS-stimulated Stim1-/-
microglia. We also found that they contributed to dramatic fluctuations in the local 
[Ca2+]micro-domains. Notably, the fluctuations completely disappeared following 
treatment with mitochondrial membrane potential disruptors; and they were 
partially inhibited by SOCE inhibitors, such as an extracellular ORAI1 antibody
(Ex-ORAI1) and the small molecule SKF-96365. Here, we suggest that the 
migration defects in Stim1-/- microglia originated with the fluctuating local 
[Ca2+]micro-domains, which is caused by mitochondrial Ca2+ buffering. 
6Here, we report that STIM1 is an critical controller of the local [Ca2+]micro-
domains that mediates purinergic activated movements of microglia, not only through 
regulating SOCE pores, but also through coordinating the mitochondrial Ca2+
buffering capacity in micro-domains at the cell periphery.
.
7II. MATERIALS AND METHODS
1. Generation of Stim1-/- mice
Stim1+/- heterozygotic mice (C57BL/6) were generated as previously 
described.6 The mice were bred and maintained according to the Yonsei Medical 
Center animal research requirements, and the Committee on Animal Research at 
Yonsei Medical Center approved all procedures (protocol number 2011-0112). As 
Stim1-/- mice die within one day of birth, embryos in the 17th day of pregnancy were 
used for experiments; and these were generated by mating of Stim1+/- female mice 
with Stim1+/- male mice. Genomic DNA isolated from the embryo tail was used for 
genotyping, and was extracted using prepGEM Tissue (PTI0200; ZyGEM, 
Hamilton, New Zealand).
2. Reagents and solutions
The reagents that Lipopolysaccharide (LPS) from Escherichia coli 0111:B4 
(L4391), thapsigargin (TG; T9033), uridine 5’-(trihydrogen diphosphate) sodium 
salt (UDP; U4125), adenosine 5’-triphosphate di(tris) salt hydrate (ATP; A9062); 
were repetitively used. All reagents were purchased from Sigma. (Sigma Aldrich, St. 
Louis, MO, USA).
For primary cell cultures, DMEM/F12 (1:1) culture medium (Dulbecco’s 
modified Eagle medium, 11320-033), Fetal bovine serum (FBS) (26140-079), 
Penicillin-streptomycin (15140-122; Gibco, Life technologiesTM, Carlsbad, CA, 
USA); Trypsin 0.25% (1x) solution (SH30042.01; Hyclone laboratories, Thermo 
scientific, Logan, UT, USA) were used. For RT-PCR analysis, TRIzol reagent 
(Invitrogen, Life technologiesTM, Carlsbad, CA, USA); AccuScript High Fidelity 1st 
Strand cDNA Synthesis Kit (200436; Agilent Technologies, Santa Clara, CA, USA); 
SolgTM 2x Taq PCR Smart mix (STD02-M10h; SolGent Co., Daejeon, Korea) were 
used.
For immunoblotting, NaCl (S7653), Triton X-100 (T8787), Glycerol (G5516; 
8Sigma Aldrich); EDTA (15694, Usb, USB Coporation, Cleveland, OH, USA); Tris 
Ultrapure (T1501, Duchefa, Haarlem, The Netherlands); Complete proteinase 
inhibitors (Roche Applied Science, Mannheim, Germany); HCl (084-05425), NaOH 
(196-05375, Wako, Osaka, Japan); BCA Protein Assay Kit (23227; PierceTM, 
Thermo Scientific, Rockford, IL, USA); 5x Tricine-SDS sample buffer (KTR020-5), 
pre-made 4-12% gradient SDS-PAGE gels (KG5012) (KOMA Biotech, Seoul, 
Korea) were used.
For Ca2+ imaging experiments, NaCl (S7653), KCl (P5405), MgCl2 (M8266), 
Glucose (G6152), HEPES (H3375), CaCl2 (C1016), EGTA (E3889), cyclopiazonic 
acid (CPA; C1530), SKF-96365 (S7809), Streptomycin (S6501), 2-APB (D9754), 
CCCP (C2759), Rotenone (R8875; Sigma Aldrich), and Fura-2 AM (F1201; 
Invitrogen, Molecular probes, Eugene, Oregon, USA) were used.
For phagocytosis, 0.4% Trypan blue stain (15250-061), 0.05% trypsin-EDTA 
(25300-062, Gibco, Life technologiesTM, Carlsbad, CA, USA); BioParticles 
Fluorescent Particles (conjugated with Alexa Fluor 488; E-13231, Invitrogen, 
Molecular probes, Eugene, Oregon, USA) were used. For Elisa assay, TNF-α 
(430901), IL-6 (431301) ELISA kit (BioLegend, San Diego, CA, USA) were used.
For in vitro and in vivo chemotaxis assay, fibronectin (F0895), methylene blue 
(66720; Sigma Aldrich) were respectively used.
For immunocytochemistry, 4% Paraformaldehyde (19943), bovine serum 
albumin (BSA) (10857; Affymetrix, Cleveland, Ohio, USA); Horse serum (16050-
122, Gibco); Gelatin (G1890), Sodium azide (S2002), Phosphate-buffered saline 
(PBS) (P5493, Sigma Aldrich) were used.
3. Antibodies and fluorescent dyes
Anti-Stim1 (610954; BD Transduction LaboratoriesTM San Jose, CA, USA), 
anti-Stim2 (4917; Cell Signaling, Danvers, MA, USA), aldolase A (N-15) (sc-12059; 
Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Iba-1 (019-19741; Wako, 
Osaka, Japan), Ex-Orai1 (ACC-062; Alomone labs, Jerusalem, Israel) and 
appropriate secondary antibodies; Alexa Fluor-FITC (A11070), Alexa Fluor-
9rhodamine (A11004, Invitrogen, Molecular probes, Eugene, Oregon, USA) were 
used. Dyes for microglia, tomato lectin (conjugated with Dylight 594, Vector Labs, 
Carlsbad, CA, USA), for nuclei, 4,6-diamidino-2-phenylindole (DAPI; D3571) and 
for mitochondria, Mito tracker Deep Red FM (M22426, Invitrogen, Molecular 
probes, Eugene, Oregon, USA). Stained cells on coverslips were mounted with 
fluorescent mounting medium (S3023, Dako, Glostrup, Denmark).
4. Isolation and culture of primary mouse microglia
Primary cell cultures of microglia were prepared from the whole brain of mice 
at embryonic day 17 (E17).45 Each embryo tail was used for genotype analysis. 
Primary mixed cells were chemically and mechanically dissociated from the whole 
brain and seeded in DMEM/F12 (1:1) supplemented with 10% FBS and 1%
penicillin-streptomycin as described previously.18 Cells were cultured at 37 °C with 
5% CO2 in an incubator (Thermo Fisher Scientific, Marietta, OH, USA).
Confluency was achieved after ~3-4 wk. After 4 wk, primary mixed cells of wild-
type (WT), Stim1-/- mice were subject to mild trypsinization by the shaking 
method.45,46 The upper cell layer of mixed cells was removed by treatment with a 
0.25% (1x) trypsin solution diluted 1:4 in culture medium for 20 min at 37 °C. The 
medium mixed with trypsin was replaced with 12 ml of fresh culture medium. The 
pure microglia attached to the bottom of the T75 flask. These cells were isolated by 
shaking the flasks at 120 rpm (SLOS-20; SeouLin Bioscience, Seoul, Korea) at 
37 °C with 5% CO2 in an incubator for 1 hr and then, all medium of each flask were 
collected separately. Each flask was refilled with 12 ml of new medium. Next, the 
collected medium were placed on a cell strainer with a pore size of 40 μm (352340; 
BD Falcon, San Jose, CA, USA) and were filtered into a fresh 15 ml conical tube. 
Centrifuge at 2,500 RCF at room temperature for 5 min. Resuspend the cell pellet 
and the number of cells was then counted using a hemocytometer (Marienfeld, 
Lauda-Königshofen, Germany).
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5. Reverse-transcriptase PCR analysis
Total RNA was extracted with TRIzol reagent according to the manufacturer’s 
instructions. cDNA was synthesised using AccuScript High Fidelity 1st Strand 
cDNA Synthesis Kit according to the manufacturer’s instructions. RT-PCR was 
performed in triplicate using SolgTM 2x Taq PCR Smart mix. Each RT-PCR reaction 
contained 100 ng of cDNA. The thermocycling conditions of RT-PCR were an 
initial denaturation at 95 °C for 5 min followed by 31~37 cycles of 95 °C for 30 sec, 
58 °C for 40 sec and 72 °C for 40 sec, and a last extension at 72 °C for 7 min.
The primer sets are provided as follows (S, sense; AS, antisense) were used for 
PCR analyses for Stim1, S, 5’-GGAAGACCTCAATTACCATGAC-3’ and AS, 5’-
GCTCCTTAGAGTAACGGTTCTG-3’ ; for Stim2, S, 5’-TGAGGATACCCTGCA
GTGG-3’ and AS, 5’-CAGTCTGCAGACTCTCTAAGTC-3’ ; for Orai1, S, 5’-
TGTTTGCCCTCATGATCAGCAC-3’ and AS, 5’-AAACTCGGCCAGCTCATTG
AG-3’ ; for Orai2, S, 5’-TTGCGATTTGCTACCAACCTG-3’ and AS, 5’-
GCTGGCTTTGGGAATTCACC-3’ ; for Orai3, S, 5’-TGCAAGCATTGCCTCAG
AAAC-3’ and AS, 5’-GGATGCCAACTGCAAAGCAG-3’.
To confirm the mRNA expression of P2 receptors, RT-PCR primer set for P2X4, 
S, 5’-ATGGCAGGCTGCTGCTCCGT-3’, and AS, 5’-AGCTGGCGTTGGCACAC
CA-3’ ; for P2X7, S, 5’-ATGCCGGCTTGCTGCAGCT-3’ and AS, 5’-TCGGCGCT
CCTCAAGAGTG-3’ ; for P2Y6, S, 5’- ATGGAGCAGGACAATGGCACC-3’ and 
AS, 5’-ACACAGTGCGGTTGCGCTG-3’ ; for P2Y12, S, 5’-ATGGATGTGCCTGG
TGTCAACACC-3’ and AS, 5’-CGTGCCAAACTAGACCAAACTCTGAC-3’ were 
used. Actin primers sets for S, 5’-GACCCAGATCATGTTTGAGACC-3’ and AS, 
5’-GGCCATCTCCTGCTCGAAGTC-3’ were used as loading control. GFAP
primers sets for S, 5’-TGATGGAGCTCAATGACCG-3’ and AS, 5’-CATCTGCCT
CCTGTCTATACGC-3’ were used as negative control.
To confirm the mRNA expression of SACCs, RT-PCR primer set for Trpv1, S, 
5’-GATGACTTCCGGTGGTGCTTCAGG-3’, and AS, 5’- CTGGGTGCTATGCCT
ATCTCGAGTG-3’ ; for Trpv2, S, 5’- GGGAGGCTGCTGAAAGTTGGC-3’, and 
AS, 5’-TGGTCTTCCTCTGAGGCACTGTTC-3’ ; for Trpv4, S, 5’-AACAAGAG
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ATGGAGGAGAAAGGTCG-3’, and AS, 5’-CTCATCAGTCAGGCGCTTCTTGT
GG-3’ ; for Trpm3, S, 5’- GGGCTTACCGCTGCAACTACACG-3’, and AS, 5’-
CGGCCCACACCATCAGCTC-3’ ; for Trpm7, S, 5’-TCCCGACAATCTGTGGT
CCTGG-3’, and AS, 5’-GATAAGAGGAGGAGGCAGGACTGG-3’ ; for Trpp2, S, 
5’- CAAGTACTGGTGAGGCGCGTGGAC-3’, and AS, 5’- CTGCTCCCTGTGG
ATCTCACTGTC-3’. 18srRNA primers sets for S, 5’-GTGGAGCGATTTGTCTGG
TT-3’ and AS, 5’-CGCTGAGCCAGTCAGTGTAG-3’ were used as loading control.
To confirm the mRNA expression of IP3R and Ryanodine (Ryr) receptors in 
ER , RT-PCR primer set for IP3R1, S, 5’-TGTTTGCTGCAAGGGTGATCTACG-3’, 
and AS, 5’-TCCTTCACTTTCACCAGCACGATG-3’ ; for IP3R2, S, 5’-ATTGTCA
CCGTGCTGAACCAGG-3’, and AS, 5’-TCACTTCTGAGGTCAGCAAACGTG-
3’ ; for IP3R3, S, 5’-AGAAGAGGACGAGGAGCCCGATAG-3’, and AS, 5’-
TCTCCAGACCACAGATGAAGCACG-3’ ; for Ryr1, S, 5’- GGCTGGTACATGG
TGATGTCCCTC-3’, and AS, 5’- GAATTTGCGGAAGAAGTTGAAGGC-3’ ; for 
Ryr2, S, 5’- TGAGTTACTGGGCATGGATAAGGC-3’, and AS, 5’- CGATGTCAA
GGAGGTGAGCAGC -3’ ; for Ryr3, S, 5’- GAGGCAGCATCTCTGGTGTCATG -
3’, and AS, 5’-CCTCAAGGTCTTAAAGCCCATTGC-3’, and the mRNA 
expression of SERCA, RT-PCR primer set for Serca1 (Atp2a1), S, 5’-
ATCTTCAAGCTCCGGGCCCT-3’, and AS, 5’-CAGCTTTGGCTGAAGATGCA-
3’ ; for Serca2 (Atp2a2), S, 5’-CTGTGGAGACCCTTGGTTGT-3’, and AS, 5’-
CAGAGCACAGATGGTGGCTA-3’.
To confirm the mRNA expression of mitochondrial Ca2+ transporters, RT-PCR 
primer set for Mcu, S, 5’-GTGGGAGCCGCATATTGCAGTAC-3’, and AS, 5’-
CCGATCCTCCTCTTGCAGTTGTC-3’ ; for Ncx1 (Slc8a1), S, 5’- GGAGCTGGC
AACATCTTGAAGAGG-3’, and AS, 5’-CAAACACAGTGGTGCTCAAGTCGC-
3’ ; for Letm1, S, 5’-GGTTGACGAGCCGTGAGAGTGTTC-3’, and AS, 5’-
CGCCCTCCTCCAGCTTCTTATTC-3’ ; for Vdac1, S, 5’-CCTCCCACATACGCC
GATCTTG-3’, and AS, 5’-ACGTCAGCCCATACTCAGTCCATC-3’ ; for Vdac2, S, 
5’-CGATGTGTATCCCTCCACCCTATG-3’, and AS, 5’-CCCAGAGTGTTATCGG
TGTTCCAC-3’ ; for Vdac3, S, 5’-GGTTGGCTTGCTGGCTATCAGATG-3’, and 
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AS, 5’-TGTTGTTGCTGCCAGCTGTCC-3’.
To confirm the mRNA expression of mitochondrial tether genes, RT-PCR 
primer set for Mitofusin-1, S, 5’-GAAAGCCATCACTGCAATCTTCGG-3’, and 
AS, 5’- AAATGCCACCTTCATATGTCTCCG-3’ ; for Mitofusin-2, S, 5’- GAGCA
ATGGGAAGAGCACCGTG-3’, and AS, 5’-GCATGGGCCAGTTGGTTCACAG-
3’ ; for Miro-1 (Rhot1), S, 5’-TCGCTGGTCAGTGAAGAATTTCCG-3’, and AS, 
5’-AGAGGAATCCATCGGCTTGTTACC-3’ ; for Miro-2 (Rhot1), S, 5’-ACGTCT
CTGATCCTGTCGCTGGTC-3’, and AS, 5’-TGGTGGTCTCCTCAGACACATCG
-3’. RT-PCR results were quantified by calculating the band intensity using Multi 
Gauge software (Fuji Film).
6. Immunoblotting
Immunoblotting was performed as described previously.47 Primary cultured 
WT and Stim1-/- microglia were seeded into 6-well plates at 2 x 106 cells/well and 
incubated overnight at 37 °C with 5% CO2 atmosphere. Then, cells were lysed in 
lysis buffer [150 mM NaCl, 5 mM Na-EDTA, 10% glycerol, 20 mM Tris-HCl, pH 
8.0, 0.5% Triton X-100, and complete protease inhibitors]. Protein concentration 
was quantified using a colorimetric method (BCA Protein Assay) according to the 
manufacturer’s instructions. The lysates, which contained 40 μg of protein, were 
eluted with 5x Tricine-SDS sample buffer, and the eluted lysates were separated on 
pre-made 4-12% gradient SDS-PAGE gels. Primary antibodies included anti-Stim1, 
anti-Stim2, and aldolase A (N-15). Appropriate secondary antibodies were used.
7. Single live cell [Ca2+]i imaging
Single live cell [Ca2+]i imaging was performed by recording [Ca2+]i using Fura-
2 AM labeling at dual excitation wavelengths of 340/380 nm, ratiometrically, as 
described previously.18 Briefly, WT and Stim1-/- microglia 5-10 x 103 cells were 
plated in the middle of 18 mm ø cover glass (Paul Marienfeld GmbH, Lauda-
Königshofen, Germany) and 3 hr after plating, cells were treated with or without 
100 ng/ml LPS for 90 min. After 60 min of LPS-stimulation, cell-permeable 2 μM 
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Fura-2 AM and incubated for 30 min with the cells at 37 °C with 5% CO2 in an 
incubator. Trapped Fura-2 fluorescence was measured with a spectrofluorometer
(Photon Technology International, Birmingham, NJ, USA). Cells were perfused 
with a solution containing 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM 
glucose, 10 mM HEPES (pH 7.4, adjusted with NaOH); containing either 1–2 mM 
CaCl2 or 5 mM EGTA (to chelate any Ca
2+ in the solution). The osmolality of all 
solutions was adjusted to 310 Osm with 2 M NaCl. The Fura-2 ratio was recorded 
using dual-excitation wavelengths of 340 and 380 nm, and emission wavelengths 
above 510 nm were monitored. Cells were treated with 25 μM cyclopiazonic acid 
(CPA), which inhibits the sarco/endoplasmic reticulum Ca2+-ATPase. Cells were 
treated with either 100 μM UDP or 50 μM ATP and then each single whole cell 
boundary was drawn for assessment of intracellular Ca2+ concentrations [Ca2+]i) 
during analysis.
A live cell Ca2+ imaging system was used to compare the local and short-lived
high [Ca2+] micro-domains in cell periphery (‘local [Ca2+]micro-domains’) of WT and 
Stim1-/- microglia flowing stimulation with either 50 μM ATP or 100 μM UDP. After 
stimulation, changes in the peripheral [Ca2+]micro-domains (∑△F) were summed over 27 
consecutive images acquired at 8 sec intervals among 108 consecutive images; The 
overlaid regions of color signify the [Ca2+]micro-domains in each microglial cell. The 
yellow box refers to (Fig. 7A, C) the period of ∑△F calculation during 260–370 sec 
after ATP-stimulation or during 250–360 sec after UDP-stimulation (Fig. 7B, D).
To check whether the local function of ORAI1 was uncontrolled in Stim1-/-
microglia, the changes of peripheral [Ca2+]micro-domains of Stim1-/- microglia were 
tested in the extreme condition.; 100 ng/ml LPS for 90 min to induce cell rounding, 
followed by stimulated with 100 μM UDP for 1 min to induce store depletion. The 
global change of [Ca2+]i (thick black line in trace) in whole cell (white dotted lines 
in ratio images, Fig. 8) was measured. Regions of interest (ROIs) in the in cell 
periphery were colored (red, green, pale blue and purple) in the ratio images, and 
the matching color curves show the changes in the peripheral [Ca2+]micro-domains
within corresponding regions. The height of the yellow box indicates the spatial 
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Ca2+ movement and the width of yellow box indicates the period of ∑△F calculation 
during 530–750 sec after UDP-stimulation in each microglia. The ∑△F were 
summed over 27 consecutive images acquired at 8 sec intervals among 108 
consecutive images (Fig. 8, the ratio of 340/380 nm images (left) and the combined 
images (∑△F, right).
After 100 ng/ml LPS-stimulation of Stim1-/- microglia for 90 min, with 5 μg/ml 
Ex-Orai1 antibody - which bind to extracellular loop of Orai1 (Fig. 10B) - or 
without such stimulation (mock cells; treated 1% BSA, 0.05% sodium azide in 
PBS); the cells were pre-incubated for 10 min at 37 °C with 5% CO2 in an incubator. 
And then the cells were stimulated by 100 μM UDP for 1 min with solution 
containing 2 mM Ca2+.
Pharmacological inhibitors used to inhibit the fluctuation included; SKF-96365 
(SOC inhibitor), Streptomycin (SACC blocker), 2-APB (IP3R inhibitor), CCCP
(protonophore) or Rotenone (Complex I inhibitor for disrupting mitochondrial 
function). After 100 ng/ml LPS-stimulation of Stim1-/- microglia for 90 min, the cell 
thoroughly washed with solutions containing 2 mM Ca2+, prior to stimulation with 
100 μM UDP for 1 min to induce store depletion. Shortly afterwards, cells were 
treated with 20 μM SKF-96365 (Fig. 10C), 200 μM Streptomycin (Fig. 10A), 100 
μM 2-APB (Fig. 9C), 0.5 μM CCCP (Fig. 9D) or 10 μM Rotenone (Fig. 9E) in 
solutions containing 2 mM Ca2+ for 8 min. The ∑△F were summed over 27 
consecutive images acquired at 8 sec intervals among 108 consecutive images (Fig. 
8-10), differential interference contrast [DIC] and the ratio of 340/380 nm images 
(left) and the combined images (∑△F, right). The yellow box indicates that the 
period of ∑△F calculation during 530–750 sec after treatment of the 
pharmacological inhibitors.
8. Phagocytosis assay
WT and Stim1-/- microglia were seeded into 12-well plates at 3 x 105 cells/well 
and incubated at 37 °C overnight. Then, cells were treated with or without 100 
ng/ml LPS and incubated for 24 hr at 37 °C with 5% CO2 in an incubator. These 
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LPS-activated microglia were treated with BioParticles and incubated for a further 2 
hr. The cells were then rinsed three times with PBS. To quench the particle 
fluorescence, cells were stained with 0.4% trypan blue at room temperature (RT) for 
2 min, and then cells were rinsed a further three times with PBS. Cells were fixed 
with 4% paraformaldehyde in PBS at RT for 10 min, and then rinsed three times 
with PBS. Nuclei were stained with 5 μg/ml DAPI. Cells were visualized on an 
inverted fluorescence microscope (IX73-F22PH, Olympus) with an excitation 
wavelength of 488 nm and emission wavelength of 520. Fluorescence intensity was 
quantified using MetaMorph software (Molecular Devices, Sunnyvale, CA, USA). 
Flow cytometry experiments were conducted as follows. WT and Stim1-/- microglia 
were seeded into 12-well plates at 3 x 105 cells/well and incubated at 37 °C
overnight. Then, cells were treated with or without 100 μM UDP and incubated at 
37 °C with 5% CO2 in an incubator for 20, 40 min. UDP-activated microglia were 
treated with BioParticles as described above. Cells were rinsed three times with 
PBS, and then to quench the BioParticles, cells were stained with 0.4% trypan blue 
at RT for 2 min, followed by rinsing three times with PBS. After treatment with 
0.05 % trypsin-EDTA at 37 °C for 10 min in 5% CO2 atmosphere incubator, the 
cells were harvested by centrifugation at 2,000 rpm at 4 °C for 5 min. Supernatant 
was removed, 500 μl ice-cold serum-free DMEM/F12 (1:1) medium was added, and 
cells were resuspended. Cells were held on ice and analyzed by flow cytometry 
using a BD FACSVerse (BD Biosciences, Franklin Lakes, NJ, USA), and a total 
gated cell number of 10,000 cells. Flow cytometry data were analyzed using FlowJo
software (Treestar, Ashland, OR, USA).
9. ELISA assay
WT and Stim1-/- microglia were seeded into 6-well plates at 2 x 106 cells/well 
and incubated at 37 °C overnight. Cells were then treated with or without 100 ng/ml 
LPS and incubated for 24 hr at 37 °C with 5% CO2 in an incubator. The next day, 
supernatants were assayed for levels of TNF-α and IL-6 using an ELISA kit 
according to the manufacturer’s instructions. Cytokine levels in LPS-activated 
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microglia were kinetically analyzed for 30 min (at 5 min intervals) using a 
VersaMax spectrophotometer plate reader (Molecular Devices, Sunnyvale, CA, 
USA) at 650 nm.
10. In vitro chemotaxis assay
Analysis of microglial migration was performed in triplicate using chemotaxis 
chambers (101-8, Neuro Probe, Gaithersburg, MD, USA) as previously described.48-
52 Polycarbonate filters with 8 μm pores were coated with 10 μg/ml fibronectin in 
PBS at RT for 1 h. The lower chambers were filled with 29 μl of serum-free 
DMEM-F12 media containing 50 μM ATP. The dry fibronectin-coated filter was 
installed to separate the lower chambers from the upper chambers. Then, WT and 
Stim1-/- microglia were seeded into the upper chambers at 4 x 104 cells/well in 20 μl 
serum-free DMEM-F12, and the chambers were incubated at 37 °C with 5% CO2 in 
an incubator for either 15, 30, 60, or 90 min. After incubation, the chemotaxis
chambers were disassembled and filters were removed. Microglial in the lower 
chambers were stained with tomato lectin (1:1000), nuclei were stained with 5 
μg/ml DAPI at RT for 10 min, and then cells were rinsed three times with PBS. 
Cells that had migrated to the lower chambers were visualized and counted using an 
inverted fluorescent microscope (IX73-F22PH, Olympus, Tokyo, Japan). The total 
number of cells stained with DAPI was quantified using MetaMorph software.
11. Microinjection of embryonic mouse brains in vivo and
immunohistochemistry.
We used microinjection to target specific regions of embryonic mouse brain in 
vivo as previously described.53 A microinjector (Nanoliter 2,000) and capillary glass 
(3.5 inches) (WPI, Sarasota, FL, USA) were used as injection tools. Timed pregnant 
Stim1+/- heterozygotic female mice carrying embryonic day 17 (E17) embryos were 
anesthetized with isoflurane and placed on a heating pad. Embryonic mice in utero
were injected with 30 nl of LPS mixed with 4% methylene blue. The final 
17
concentration was 12 ng of LPS per one embryo in utero. The mother was sutured 
and recovered on a warming pad for 1 h, and then moved back to her home cage. 
After 24 hr, the mother was re-anesthetized with isoflurane and the abdominal 
incision was reopened to approach the embryos. After the embryos were taken out 
of the uterus, the mother was necessarily sacrificed. Embryonic whole brains were 
fixed with 10% formalin at 4 °C overnight. Then, tissue was transferred to 3 M 
sucrose in PBS solution and incubated at 4 °C until the tissue sank to the bottom of 
the tube (a couple of hours). This sucrose-infiltration is necessary for tissue 
cryopreservation. The fixed embryo brain tissue was used for cryosectioning, and 
embryo tails were used for genotype analyses. Sections of embryonic WT and 
Stim1-/- brains were labeled in blocking solution with anti-Iba-1, an antibody 
specific for microglia, and a secondary antibody labeled with Alexa Fluor 488, 
followed by rinsing three times with PBS. Nuclei were stained with 5 μg/ml DAPI. 
After rinsing, coverslips were mounted using fluorescent mounting medium and 
visualized under a confocal microscope (LSM 710 controlled with Zen software, 
Carl Zeiss, Jena, Germany). The total number of cells in lesioned and counterpart 
areas was measured by computer vision using MetaMorph software. More than 3 ea 
of WT and Stim1-/- embryonic mice were analyzed. The relative morphological 
responses were measured by the average shape factor using computer vision and 
MetaMorph software. The shape factor, defined as 4πA/P2 (A and P are the cell area 
and perimeter, respectively), approaches unity for round shaped cells.
12. Immunocytochemistry
Primary cultured WT and Stim1-/- microglia were seeded on glass cover slips 
placed into 24-well plates at 5 x 104 cells/well, and incubated overnight at 37 °C 
with 5% CO2 in an incubator. Cells were treated with or without 1 μM TG for 5 min, 
100 μM UDP for 40 min or 100 ng/ml LPS for 90 min, before being fixed with 4% 
paraformaldehyde in PBS at RT for 10 min, followed by rinsing three times with 
PBS. To avoid non-specific antibody binding, cells were treated with blocking 
solution [5% horse serum, 1% BSA, 0.1% gelatin, 0.001% sodium azide in PBS, pH
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7.4] at RT for 30 min. To detect functional ORAI1 at the cell surface, an antibody 
recognizing the extracellular loop of Orai1 (Ex-Orai1) was used under non-
permeabilizing conditions, which prevented antibody penetration into cells. After 
Ex-Orai1 labeling with primary and secondary antibodies, cells were permeabilized 
and STIM1 was labeled. Cells were permeabilized by incubating in 
permeabilization solution [0.1% Triton X-100, 1% horse serum, 1% BSA in PBS, 
pH7.4] at RT for 5 min, and were then rinsed three times with PBS. Immunostaining 
was performed in blocking solution using 1:100 dilution Ex-Orai1 or 1:100 dilution 
of anti-Stim1 as primary antibodies, followed by the appropriate secondary 
antibodies tagged with Alexa Fluor-FITC (1:200) or Alexa Fluor-rhodamine (1:200). 
Nuclei were stained with 5 μg/ml DAPI. The coverslips were rinsed, mounted with 
fluorescent mounting medium, and cells were visualized on a confocal microscope.
For mitochondrial staining, primary cultured WT and Stim1-/- microglia were 
seeded on glass cover slips into 24-well plates at 5 x 104 cells/well and incubated 
overnight at 37 °C with 5% CO2 in an incubator. Cells were treated with or without 
100 ng/ml LPS for 90 min and were stained with 200 nM Mito Tracker in culture 
medium for 10 min at 37 °C in an incubator, and nuclei were stained with 5 μg/ml 
DAPI. Following staining, cells were fixed with 4% paraformaldehyde in PBS at RT 
for 5 min and mounted with fluorescent mounting medium.
13. Transmission Electron microscopy
Each 1 x 105 cells/well of WT and Stim1-/- microglia were seeded on 12 mm 
diameter inserts of transwell plate (Corning, 3460, USA) with or without LPS, and 
incubated for 90 min at 37 °C with 5% CO2 in an incubator. Cells were centrifuged 
and the supernatant was removed. The pellets were resuspended and fixed with 
solution [2% Glutaraldehyde - Paraformaldehyde in 0.1 M phosphate buffer (PB)
(pH 7.4)] for 12 hr, and washed out with 0.1 M PB. Cells were post-fixed with 1% 
OsO4 dissolved in 0.1 M PB for 2 hr and dehydrated in ascending gradual series
(50~100%) of ethanol and infiltrated with propylene oxide. Specimens were 
embedded by Poly/Bed 812 kit (Polysciences). After fresh resin embedding and 
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polymerization at 65℃ electron microscope oven (TD-700, DOSAKA, Japan) for 
24 hr. Thick section of about 200–250 nm was firstly cut and stained with toluidine 
blue (sigma, T3260) for light microscope. Thin section of about 80–100 nm were 
double stained with 6% uranyl acetate (EMS, 22400 for 20 min) and lead citrate
(Fisher, for 10 min) for contrast staining. These sections were cut by LEICA EM 
UC-7 (Leica Microsystems, Austria) with a diamond knife (Diatome) and 
transferred on copper grids. The images of thin section were visualized using 
camera-Megaview III (Soft imaging system-Germany).
14. Statistical analysis
Data are presented as the means ± standard error of the mean. Statistical 
analysis was performed with Student's t-test or with analysis of variance (ANOVA), 
followed by Tukey's multiple comparison and one-way or two-way ANOVA tests 
using the GraphPad Prism software package (version 5.0), as appropriate. P<0.05 
was considered statistically significant.
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III. RESULTS
1. Validation of the expression of SOCE components and their function 
in primary cultured WT and Stim1-/- microglia
Both ORAI and STIM proteins are major components of the SOCE system. 
We tested the mRNA expression of each isoform of Orai- (Orai1, Orai2, and Orai3) 
and Stim- (Stim1 and Stim2) families in C57BL/6 strain WT and Stim1-/- primary 
cultured microglia using RT-PCR analysis, checking for any alterations in gene 
expression. The purity of microglial cDNA was confirmed by GFAP-negative 
results; β-actin was used as control for cDNA loading. Orai1, Orai2, and Orai3, 
and Stim2 were expressed in both microglial cell types (Fig. 1A). Stim1-/- microglia 
did not contain Stim1 transcripts, and had slightly elevated Orai2 expression.
In addition, the expression of STIM1 and STIM2 expressions was analyzed 
by measuring LPS-induced protein levels (Fig. 1B). Production of STIM1 protein 
was increased by LPS treatment in WT, while STIM2 was slightly increased. These 
results testify that STIM1 is the primary SOCE regulator in microglia.
The Ca2+ influx induced by internal Ca2+ store depletion was compared to 
basal [Ca2+]i levels by measuring Fura-2 AM loading inside microglia. These cells 
had been treated with CPA, which inhibits SERCA; the sarco/endoplasmic 
reticulum Ca2+ ATPase (Fig. 1C-F). Relative to WT cells, Stim1-/- microglia had a 
reduced basal [Ca2+]i, reduced internal Ca2+ store, and Ca2+ influx was essentially 
blocked. These data demonstrate that STIM1 is a major regulator of SOCE in 
microglia.
21
Figure 1. Expression of mRNA and functioning of SOCE elements in primary 
cultured microglia from WT and Stim1-/- mice. (A) Expression of mRNA 
transcripts for members of the Orai- and Stim- families in purified WT and Stim1-/-
microglia. Whole mouse brain extract was used as a positive control for RT-PCR; β-
actin was used as loading control for cDNA. (B) STIM1 and STIM2 proteins were 
identified by immunoblotting in lysates of purified microglia from WT and Stim1-/-
mice. Aldolase A was used for loading control. (C) Single live cell [Ca2+]i imaging 
was monitored as described in the Material and methods section. CPA-induced 
[Ca2+]i changes in WT and Stim1-/- microglia are depicted. Representative traces are 
shown, giving the [Ca2+]i in each cell measured using Fura-2 AM. Cells were treated 
with 25 μM CPA to deplete internal Ca2+ stores, and then SOCE was monitored in a 
2 mM Ca2+ perfusion solution. (D) Comparisons between WT and Stim1-/- microglia
of the basal [Ca2+]i, (E) the relative internal Ca2+ store amounts calculated by CPA-
evoked Ca2+ peaks, and (F) the CPA-induced SOCE activity as calculated from the 
slope of Ca2+ influx. ***P≤0.0001 relative to WT values (n>30), and at least three 
independent experiments were used to calculate the average.
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2.  Comparisons of LPS-stimulated phagocytosis and cytokine secretion 
between WT and Stim1-/- microglia
LPS is a potent immune activator of microglia, which binds to TLR4 and 
activates receptor signaling.23 The effects of STIM1 on microglial immune function, 
phagocytic activity, and cytokine secretion was compared between WT and Stim1-/-
microglia.18 To assess phagocytic activities in WT and Stim1-/- microglia after 
differentiation, both resting and LPS-treated (100 ng/ml for 24 hr) cells were 
compared for their ability to engulf E.coli opsonized with FITC-labeled bio-
particles. Microglial were treated with bio-particle beads for 2 hr. Then, free beads 
and attached beads on the cell surface were quenched by trypan blue, and beads 
inside of cells were visualized using fluorescence microscopy (Fig. 2A, B). In WT 
cells, LPS treatment for 24 hr increased phagocytic activity approximately 2.5-fold.
In contrast, Stim1-/- microglia only showed small increases in phagocytic activity
following LPS treatment. These results clearly demonstrated that the magnitude of 
phagocytic activity following differentiation by LPS, was decreased in Stim1-/-
microglia.
Next, we compared LPS-induced secretion of the pro-inflammatory cytokines,
TNF-α and IL-6 (Fig. 2C, D). The results showed that the amount of these cytokines 
secreted by Stim1-/- microglia was less than half the amount secreted by WT 
microglia. These data indicate that the absence of STIM1 leads to reduced 
phagocytic activity and cytokine section in microglia differentiated by LPS.
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Figure 2. Comparisons of LPS-induced phagocytosis and cytokine secretion 
between WT and Stim1-/- microglia. (A) Representative images of the compared 
phagocytosis measurements. (B) Summary of five independent phagocytosis 
measurements. Seven images were used for phagocytosis measurements and then 
depicted as a bar graph. ***P≤0.0001 in LPS-induced fold-induction of WT, n=7.  
Comparisons of LPS-induced cytokine secretion activity: (C) TNF-α secretion and 
(D) IL-6 secretion were compared in WT and Stim1-/- microglia. ***P≤0.0001, n=4; 
(ns, no significant difference from WT mock).
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3. Impairment of UDP-induced phagocytosis in Stim1-/- microglia
Phagocytosis is activated primarily by the expression of “eat-me” signals on the 
surface of damaged or dead cells. Injured neurons leak diffusible UDP, which acts 
as a signal to activate P2Y6-dependent phagocytic signaling in microglia
33,54,55. UDP, 
which also acts on Gq-coupled P2Y6 receptors, induces the expression of 
chemokines.56 In contrast to the positive effect of P2Y6, stimulation of P2X7 or P1 
receptors attenuates microglial phagocytosis.57,58 We first established the mRNA 
levels of P2X4, P2X7, P2Y6, P2Y12 receptors in primary cultured WT and Stim1-/-
microglia (Fig. 3A). We measured dose-dependent UDP-induced (at 0.1, 1, 10, 100
μM) [Ca2+]i increases in WT and Stim1-/- microglia (Fig. 3B). In WT microglia, the 
[Ca2+]i was increased by UDP in a dose-dependent manner, but Stim1-/- microglia 
did not show any such increase in the [Ca2+]i, due to depletion of the internal Ca2+
store. As expected, Stim1-/- microglia did not show any sustained Ca2+ influx after 
an initial UDP-induced transient increase in the [Ca2+]i (Fig. 3C-E). These results 
confirm that the P2Y6-induced Ca
2+ release from the ER induces the store depletion-
mediated Ca2+ influx, has been abolished in Stim1-/- microglia. Microglia express 
many of the P2 purinoceptors; P2X receptors, ionotropic receptors, which can be 
opened mainly by the binding of ATP, and P2Y receptors, metabotropic receptors, 
which can bind either purines or pyrimidines and activate downstream signaling
cascades through G-proteins.23,59 The P2X4, P2X7 and P2Y12 of microglia are 
activated by ATP,49 and these cells also express the P2Y6 receptor which activated by 
UDP.33,56
To examine microglial phagocytosis activity precisely, we used using FACS 
(Fluorescence-Activated Cell Sorting) to measure the phagocytic engulfment of 
E.coli that had been opsonized with FITC-labeled bio-particles (Fig. 3F, G). After 
phagocytic beads engulfment for either 20 or 40 min, with or without UDP, 
microglia were detached by trypsin, and then the fluorescence from beas in each 
cell was counted by FACS. Fig. 3F shows representative FACS images for WT and 
Stim1-/- microglia. A summary of the phagocytosis of WT and Stim1-/- microglia 
after 20, 40 min of UDP treatment, is presented in Fig. 3G. As can be seen, Stim1-/-
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microglia had severe defects in UDP-induced phagocytosis. These data establish
that STIM1 is a major frontline component of the UDP-induced phagocytosis 
process via its regulation of Ca2+ signaling following purinergic receptor activation.
Figure 3. UDP-induced Ca2+ signaling and phagocytosis in WT and Stim1-/-
microglia. (A) The mRNA level of P2 receptors was measured via RT-PCR analysis. 
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(B, C) Single live cell imaging of the [Ca2+]i was monitored as described in Material 
and methods section. Each curve represents intracellular Ca2+ concentrations 
([Ca2+]i) during the experiments. (B) Representative trace of dose-dependent UDP-
induced transient Ca2+ releases from the ER store in WT and Stim1-/- microglia. (C)
Representative curves of 100 μM UDP-induced intracytoplasmic Ca2+ mobilization 
in WT and Stim1-/- microglia; 100 μM UDP-induced Ca2+ release from the ER, upon
store depletion Ca2+ influx occurred. (D) Quantification of the relative UDP-induced 
transient Ca2+ released from the ER. ***P≤0.0001, n=15. (E) Comparison of UDP-
induced SOCE activity calculated from the slope of the Ca2+ influx. ***P≤0.0001, 
n=15. (F) Representative flow cytometry images of the phagocytosis measurements. 
The intensity of FITC following phagocytic beads engulfment, in the presence of 
absence 100 μM UDP, was measured at 20 and 40 min. Fluorescence profiles for
each group of cells are shown [no beads (black), beads only (blue), and beads +
UDP (red)]. High fluorescence populations (gated region) were interpreted as beads
engulfing cells. (G) Summary of FACS from three independent phagocytosis 
experiments. The geometric mean in the gated region represents the relative 
phagocytic activity in each set. **P≤0.001 in comparison to beads engulfment by
WT microglia.
4.  Severe defects in the chemotaxis of Stim1-/- microglia in vitro and in 
vivo
Low ATP concentrations almost universally activate immune cell chemotaxis,
in order to attract cells to the site of injury or inflammation.49 Conversely, when the 
ATP concentration increases, additional immune effector functions, such as 
phagocytosis and cytokine secretion, are triggered.48,49,55,60,61 To compare the ATP-
induced Ca2+ signaling in WT and Stim1-/- microglia, we monitored the [Ca2+]i by 
measuring Fura-2 AM fluorescence following the addition of 50 μM ATP (Fig. 4A). 
Changes in the [Ca2+]i were calculated by measuring the area under the curve 
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(AUC), which quantified the magnitude of Ca2+ influx upon ATP stimulation.
Relative to WT cells, Stim1-/- microglia experienced a smaller Ca2+ influx (Fig. 4B).
Next, we performed in vitro chemotaxis experiments by stimulating with 50
μM ATP (Fig. 4C).48,49,51,61 The number of cells that had migrated into the ATP 
chamber, after 15, 30, 60, and 90 min, were subsequently counted by DAPI staining. 
The extent of WT microglial migration increased in a time-dependent manner. In 
contrast, Stim1-/- microglia did not show a time-dependent increase in migration, 
and the number of such cells found bottom of chamber was about one-third of the 
number recorded for the WT cells. These results demonstrate that Stim1-/- microglia 
have severe defects in their chemotatic response to ATP.
To test the in vivo behavior of Stim1-/- microglia in brains, we injected 30 nl of 
LPS mixed with methylene blue in the 17 day old embryo brains.53 Methylene blue 
was used to detect the injection site in brain slices. A full 24 hr after injection, each 
of embryo brains were harvested and their genotypes were checked. WT and Stim1-/-
brains were sectioned to 16 μm slices, and those sections marked with methylene 
blue were selected and stained with Iba-1 to visualize microglia. Fig. 4D shows 
representative WT and Stim1-/- brain slice images under differing levels of
magnification.
In the WT brain, Iba-1 positive cells had aggregated around the injected LPS 
lesion, but the counterpart region of the non-injected hemisphere showed normal 
ramified microglia. High-magnification images of both sides showed the distinctive
morphologies of microglia in the ramified/resting and amoeboid/activated state. In 
the case of Stim1-/- brain tissue, only a few microglia had crowded in the LPS 
lesions. Although lesion-localized Stim1-/- microglia had a similar amoeboid shape 
as the WT cells, Stim1-/- brain slices showed distinctly decreased numbers of 
microglia aggregated in lesion; suggesting that Stim1-/-microglia have a defect in 
migration activity toward injured regions (Fig. 4E).
In the injected legions, the morphology of microglia, which represents the level 
of differentiation, was almost identical in WT and Stim1-/- microglia when their
roundness was compared by shape factor (Fig. 4F). We intended to calculate the 
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extent of phagocytic engulfment of methylene blue particle inside the microglia, but 
we were unable to measure them because the exposed areas of microglia containing 
engulfed methylene blue particles were not uniform. These data illustrated that 
Stim1-/- microglia have severe defects in migration, among other immunological
activities, and that STIM1 is crucial for microglial chemotaxis in vitro and in vivo.
Figure 4. Chemotaxis of WT and Stim1-/- microglia in vitro and in vivo. (A)
Single live cell [Ca2+]i imaging was monitored. Representative curves of 50 μM 
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ATP-induced mobilization of intracytoplasmic Ca2+ in WT and Stim1-/- microglia. 
Stim1-/- microglia had lower elevations in the [Ca2+]i than WT cells. (B) The relative 
ATP-induced Ca2+ magnitude derived from the area under the curve. ***P≤0.0001, 
n>30. (C) Time-dependent migration toward 50 μM ATP determined in chemotaxis 
chambers. Cells that had migrated towards the ATP source were fixed and stained 
with DAPI and were counted. The number of migrated cells at each time point was 
determined from six independent experiments and is depicted graphically. *P≤0.005, 
**P≤0.001 and ***P≤0.0001 versus the corresponding control (two-way ANOVA, 
n=6). (D) Microglial aggregation at the site of LPS/methylene blue (MB) injection 
in embryonic brains of WT and Stim1-/- mice. No LPS injection (upper right 
hemisphere) and LPS-injected (lower left hemisphere) are indicated in low-
magnification images with immunostaining by Iba-1 antibody. Merged images of 
Iba-1- FITC and gray-DIC are shown in b-e and g-j; microglia are shown in green 
and methylene blue particles are shown in gray. Resting/ramified microglia (b, c, g,
h) were identified in the non-injected hemisphere, and the amoeboid shapes of 
differentiated microglia engulfing methylene blue particles (d, e, i, j) were identified 
only in the region injected with LPS + MB. (E) The number of Iba-1 positive 
microglia was counted at the LPS + MB injection site and in the non-injected site. 
(F) Relative morphological changes of WT and Stim1-/- microglia in vivo. Shape 
factors of microglia at the LPS injection site were determined and compared (a 
circle has a shape factor = 1). *P≤0.05; (ns, no significant difference from WT 
mock). Data are representative of three experiments.
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5. Formation of ORAI1 surface-clusters is mediated by STIM1 upon
internal Ca2+ store depletion
To figure out how co-operative between STIM1 and ORAI1 in microglia, we 
visualized the STIM1 and ORAI1 localization in WT and Stim1-/- microglia under 
store-depleted (Fig. 5, 6). To detect functional ORAI1 at the cell surface, an 
antibody recognizing extracellular loop of ORAI1 was used under non-
permeabilizing conditions, which did not allow antibody penetration into cells. 
After ORAI1 labeling with primary and secondary antibodies, cells were 
permeabilized and STIM1 was labeled.
Resting WT microglia had small clustered STIM1 and ORAI1 structures, only 
some of them were co-localized at the resting condition. However, the cluster sizes 
of both proteins increased within 10 min after treatment with 1 μM TG and their co-
localization was increased. Most interestingly, in increased cluster size of ORAI1 in 
response to TG stimulation was dramatically increased in WT microglia (Fig. 5A, D) 
and the increased ORAI1 clusters were co-localized with the increased STIM1
clusters (Fig. 5C, 6C). Unexpectedly, ORAI1 at the cell surface also increased in 
Stim1-/- microglia after TG stimulation (Fig. 5B, E). However, the increase cluster 
size of ORAI1 was not observed. These results offered that the only the clustered 
ORAI1 co-localized with STIM1 was functional in global [Ca2+]i increment (Fig. 
5D). These results show that STIM1 and ORAI1 work in co-operative upon store 
depletion conditions. In addition, ORAI1 localization at the cell surface is possible 
without STIM1, but STIM1 is obviously required for functional ORAI1 increasing 
global [Ca2+]i.
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Figure 5. STIM1 is required for the formation of ORAI1 surface-cluster, but 
not for ORAI1 insertion into the plasma membrane in microglia. (A, B) Surface 
ORAI1 (green) and STIM1 (red) were immunostained and visualized with confocal 
microscopy under non-permeabilising immunostaining using an antibody specific 
for the extracellular loop of ORAI1 (Alomone); STIM1 was subsequently 
immunolabeled after cell permeabilization in WT microglia and Stim1-/- microglia 
treated with TG (1 μM for 10 min). Insets are high-magnification excerpts from the 
whole-cell images (Bar=20, 5 μm) to show co-localized clusters (yellow spots; 
Bar=2, 1 μm). In each panel, the left image shows low-magnification visualization 
of the gross ORAI1 distribution in cells (Bar=20 μm), and the next three (WT) and 
two (Stim1-/-) high-magnification images show details of cluster size and 
distribution of each protein; merged images show co-localized protein clusters 
(yellow spots). Dotted lines indicate the cell border in each image. (A, C)
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Thapsigargin (TG) induced co-localization of STIM1 and ORAI1 in WT microglia. 
(B, E) Treatment with 1 μM TG for 10 min increased ORAI1 localization at the cell 
surface throughout the cell border in WT and Stim1-/- microglia, (D) but ORAI1
clusters co-localized with STIM1 clusters increased in size only in WT microglia
6.  Peripheral/central localization of ORAI1 is controlled by STIM1
under UDP/LPS-stimulation
To test whether the central or peripheral localization of ORAI1 was controlled 
by STIM1, we compared localization of ORAI1 under UDP or LPS treatment which 
induce acute phagocytic movement and chronic differentiation of microglia through
alterations in gene expression, respectively.62 During the resting state, ORAI1 was 
only found at the cell periphery. After 40 min UDP treatment, ORAI1 clusters in 
peripheral region were significantly increased and some of them were co-localized 
with STIM1 clusters in WT microglia (Fig. 6A). Such clusters of ORAI1 in 
peripheral regions were not observed in Stim1-/- microglia (Fig. 6B).
The opposite phenomenon was observed in LPS-stimulated conditions. LPS 
treatment for 90 min caused dramatic re-localization of STIM1 and ORAI1 to the 
cell center near the nucleus, which may cause efficient and marked increase of 
[Ca2+]i in WT microglia (Fig. 6D). By contrast, Stim1-/- microglia exhibited 
relatively diffuse ORAI1 localization throughout the cell, and the LPS-induced re-
localization of STIM1 and ORAI1 to the cell center was not as profound as that 
seen in the in WT cells (Fig. 6E). The intensity of surface ORAI1 in the cell 
periphery was calculated from the intensity of ROIs (0.65 μm away from the edge 
of cell) using MetaMorph software. (Fig. 6C, F). These results suggested that 
STIM1 is important for ORAI1 localization near the nucleus, which drives a global 
increase in the [Ca2+]i in response to LPS stimulation. Moreover, STIM1 is crucial 
for ORAI1 localization in the cell periphery [Ca2+]micro-domains that controls fast and 
transient Ca2+ signaling required for phagocytic movement.
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Figure 6. STIM1 controls ORAI1 localization at the cell periphery. (A-C) UDP 
and (D-F) LPS induce co-localization of STIM1 and ORAI1 in WT microglia (A, D)
and Stim1-/- microglia (B, E), respectively. Treatment with 100 μM UDP for 40 min 
increased ORAI1 localization at the cell surface throughout the cell border (A) in 
WT and (B) Stim1-/- microglia. Insets were magnified in the remaining images (A, D)
and (B, E). The ORAI1-FITC intensity profile (red lined region) is shown in each of 
the right-most images. The cell border iss signified by dotted lines and clustered 
ORAI1 is indicated by arrows. (C, F) The intensity of surface ORAI1 in the cell 
periphery was compared (C) in UDP or (F) LPS treated cells. The intensity of 
surface ORAI1 in cell periphery was calculated from the intensity of ROIs, (0.65 
μm away from the edge of cell) using MetaMorph software.
7. The local [Ca2+]micro-domains fluctuates in Stim1-/- microglia
Intracellular Ca2+ is the principal factor for migration of both immune and 
cancer cells.36,63 Local and short-lived micro-domains contain high concentrations 
of Ca2+ cations, sometimes called ‘calcium flickers’. The sophisticated
spatiotemporal configuration of Ca2+ micro-domains can harmonize complicated
cellular processes such as cell migration.36,64,65 In the migrating cell, the Ca2+
concentration creates a local Ca2+ gradient.64 Both local and global Ca2+
concentrations exert a considerable impact upon cellular functions. We also showed 
that the migration activity was reduced in Stim1-/- microglia using a chemotaxis 
chamber in vitro (Fig. 4C) and in Stim1-/- embryonic brains using microinjection in 
vivo system (Fig. 4D-F). Since the Stim1-/- microglia abolish acute movements, such 
as migration and phagocytosis, we routinely observed the changes of [Ca2+]i after 50 
μM ATP (Fig. 7A, B) or 100 μM UDP-stimulations (Fig. 7C, D) using single live 
cell [Ca2+]i imaging. After that we visualized the combined images using 
MetaMorph software and found the generation of ‘local Ca2+ concentration micro-
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domains in the cell periphery’ (referred to hereafter as ‘local [Ca2+]micro-domains’) was
noticeably higher in Stim1-/- microglia than in WT cells (Fig. 7B, D; see the
combined images ∑△F, right). Then, we measured not only the global change in the 
[Ca2+]i (thick black line in trace) in single whole cells (white dotted lines in DIC or 
ratio images, Fig. 8), but also the local [Ca2+]micro-domains in both WT (Fig. 8A) and 
Stim1-/- microglia (Fig. 8B, 9A). ROIs are colored by ratio, and are depicted 
alongside the matching color curves to show the changes in peripheral regions. 
Most strikingly, we noticed a surprising feature in the pattern of Ca2+ movements.
These showed sporadic and jerky movements in cell periphery of Stim1-/- microglia.
Figure 7. Stim1-/- microglia showed high [Ca2+]micro-domains changes in the cell 
periphery. (A, C) Single live cell [Ca2+]i imaging was monitored. Representative 
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curves of (A) 50 μM ATP or (C) 100 μM UDP-induced [Ca2+]i mobilization in WT 
and Stim1-/- microglia. The ratio images (340/380 nm, left) and the combined 
images ∑△F (right) of high-[Ca2+]micro-daomain in cell periphery of WT and Stim1-/-
microglia after 50 μM ATP (B) or 100 μM UDP-stimulation (D) were shown; The 
∑△F (a.u.) were summed over 27 consecutive images acquired at 8 sec intervals 
among 108 consecutive images and analyzed by MetaMorph software. (a.u.;
arbitrary units). The yellow box (A, C) indicates the period of ∑△F calculation after 
50 μM ATP-stimulation (260–370 sec) and after 100 μM UDP-stimulation (250–360 
sec; Fig. 7B, D).
Figure 8. The peripheral region of LPS-stimulated Stim1-/- microglial showed a
fluctuating local [Ca2+]micro-domains. (A, B) Single live cell [Ca2+]i imaging was 
monitored. (A) WT or (B) Stim1-/- microglia were initially treated with 100 ng/ml 
LPS for 90 min, and then stimulated with 100 μM UDP for 1 min in 2 mM Ca2+
solution. A single whole cell boundary ROI is shown in white dotted lines on the 
DIC images. Ratio and ∑△F(a.u.) images and representative curves of single whole 
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cells are shown (thick black line) in ratio images (340/380 nm). Colored ROIs were 
depicted in cell periphery and matching color-curves show the [Ca2+]micro-domains in 
corresponding regions. The movements of Ca2+ concentration changes (∑△F) were 
summed over 27 consecutive images acquired at 8 sec intervals among 108 
consecutive images during the section of 530–750 (sec) after 100 μM UDP-
stimulation for 1 min (Fig. 8, see the ratio of 340/380 nm (left) pattern and 
combined images (∑△F, right).
8. Fluctuations in the local [Ca2+]micro-domains in Stim1-/- microglia 
disappear following collapse of the mitochondrial membrane 
potential
To test the contribution of external Ca2+ to the fluctuation of [Ca2+]micro-domains
in the peripheral region of Stim1-/- microglia (Fig. 7, 8), we firstly performed that 
Stim1-/- microglia were firstly treated with 100 ng/ml LPS for 90 min, and 
stimulated with 100 μM UDP for 1 min in 2 mM Ca2+ solution. Then, we changed 
the bath solution from in 2 mM Ca2+ to Ca2+-free with 5 mM EGTA (Fig. 9B). 
Under the extracellular Ca2+-free conditions, the height of fluctuations in [Ca2+]micro-
domains in the cell periphery was slightly reduced, but still clearly showed huge 
fluctuations of [Ca2+]micro-domains in the cell periphery in Stim1-/- microglia. These data 
indicate that the main cause of the fluctuating local [Ca2+]micro-domains dose not derive 
from external Ca2+ sources.
The next question we investigated was which intracellular organelles might
contribute to this phenomenon. At first, we checked for altered mRNA expression of 
Ca2+ mobilizing proteins in the ER and mitochondria via RT-PCR experiments. 
Expression of the mRNAs encoding IP3R-, Ryanodine (Ryr) receptors and Serca- in 
the ER (Fig. 9F, G) and the mRNA expression of the Mcu (mitochondrial Ca2+
uniporter), Ncx1 (Na+/Ca2+ exchanger), Letm1 (Ca2+/H+ antiporter) and Vdac
(voltage-dependent anion channel; one of the component proteins of mitochondrial 
permeability transition pore [MPTP]) in mitochondria (Fig. 9H) was measured. We 
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compared these levels and we did not find increases in ER Ca2+ mobilizing proteins.
However, some of mitochondrial Ca2+ mobilizing proteins (MCU, NCX1, Letm1) 
were notably increased in Stim1-/- microglia. Secondly, we tested the effect on the 
fluctuating local [Ca2+]micro-domains of inhibiting the IP3 receptor, which is the main 
Ca2+ mobilizing proteins in the microglial ER; we also tested the effect of two 
disruptors of the mitochondrial membrane potential. IP3R inhibition (2-APB; 2-
Aminoethyl diphenylborinate, 100 μM) did not have any effect on the fluctuating
local [Ca2+]micro-domains in Stim1-/- microglia (Fig. 9C). Surprisingly, however, both 
carbonyl cyanide 3-chlorophenylhydrazone (CCCP, 0.5 or 1 μM, Fig. 9D) and 
rotenone (10 μM , Fig. 9E) have a great inhibitory effect on the fluctuating local
[Ca2+]micro-domains in Stim1-/- microglia. CCCP is a protonophore which disrupts the 
mitochondrial membrane potential and rotenone binds to Complex I (NADH 
dehydrogenase), inhibiting the mitochondrial respiratory chain. These data indicate 
that the main source of the fluctuating local [Ca2+]micro-domains in microglia derived, 
not from the ER, but from mitochondria.
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Figure 9. Fluctuations in the local [Ca2+]micro-domains in Stim1-/- microglial 
disappear following treatment with mitochondrial membrane potential
disruptors. (A-E) Single live cell [Ca2+]i imaging was monitored. Stim1-/- microglia 
were treated 100 ng/ml LPS for 90 min and then stimulated with 100 μM UDP for 1 
min (A) in 2 mM Ca2+ solution or (B) in Ca2+-free solution with 5mM EGTA. (C, D, 
E) Stim1-/- microglia were treated 100 ng/ml LPS for 90 min, and then stimulated 
with 100 μM UDP for 1 min in 2 mM Ca2+ solution. Then inhibitors such as (C) 100 
μM 2-APB, (D) 0.5 μM CCCP and (E) 10 μM rotenone were added in 2 mM Ca2+
solution, respectively. The combined images (∑△F, right) were analyzed during
530-750 (sec). (F, G) Expression of mRNA transcripts for members of the IP3R-, 
Ryr- and Serca- families in ER, and (H) Mcu, Ncx1, Letm1, Vdac- in mitochondria
in purified WT and Stim1-/- microglia. Whole mouse brain tissue was used as 
positive control for RT-PCR; 18srRNA was used as control for cDNA loading.
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9.  Fluctuations in the local [Ca2+]micro-domains are influenced by SOCE 
inhibition
Previously, we showed that ORAI1 localization at the cell surface is increased 
in Stim1-/- microglia (Fig. 5B, E), so we considered what the function of ORAI1
might be when its localization on the cell surface becomes increased, without 
STIM1. Moreover, Fig. 6E suggested that the LPS treated Stim1-/- microglia, large 
amounts of ORAI1 remained in the peripheral region. These data implied that 
uncontrolled ORAI1 function may exist in Stim1-/- microglia. Furthermore, we 
previously confirmed that there is a minor reduction in the fluctuations in the local
[Ca2+]micro-domains in Stim1-/- microglia when placed in a Ca
2+-free solution (Fig. 9B). 
So, we expected that ORAI1 might have some effect on to the fluctuating local
[Ca2+]micro-domains.
To test this hypothesis, we subsequently performed the same experiments, but 
this time we pre-incubated with Ex-Orai1 antibody or omitted antibody (mock 
treatment) for 10 min before experiments. The mock set showed a similar pattern to
Stim1-/- microglia (data not shown), but with the Ex-Orai1 antibody incubation set 
showed remarkably calm and equable changes in the [Ca2+]micro-domains in peripheral 
regions of the cells (Fig. 10B). Additionally, the pharmacological SOC inhibitors,
SKF-96365, produced a striking reduction in the fluctuations of the local [Ca2+]micro-
domains (Fig. 10C). However, 200 μM streptomycin (a SACC blocker)64 did not 
produced a noticeable change (Fig. 10A), although the mRNA levels of TRPV2, 
TRPM7, and the SACCs (stretch-activated Ca2+ permeant channels of the transient 
receptor potential superfamily) were clearly detected by RT-PCR (Fig. 10D). These 
comprehensive results suggest uncontrolled SOCE; and that ORAI1 partially 
contributes to the fluctuating local [Ca2+]micro-domains in Stim1-/- microglia.
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Figure 10. Fluctuations in the local [Ca2+]micro-domains were influenced by SOCE 
inhibitors. (A-C) Single live cell [Ca2+]i imaging was monitored. Stim1-/- microglia 
were pre-treated with 100 ng/ml LPS for 90 min, and then stimulated with 100 μM
UDP for 1 min in a 2 mM Ca2+ solution. The combined images (∑△F, right) were 
analyzed during 530–750 sec. Stim1-/- microglia were pre-treated 100 ng/ml LPS for 
90 min, and stimulated with 100 μM UDP for 1 min in a 2 mM Ca2+ solution. Then 
the cells were placed in a 2 mM Ca2+ solution and treated with either (A) 200 μM 
streptomycin, or with (C) 20 μM SKF-96365. (B) After pre-treatment of LPS, cells 
were pre-incubated with the extracellular ORAI1 antibody (Ex-Orai1) for 10 min at 
37 °C with 5% CO2 in an incubator, before being stimulated with 100 μM UDP. (D)
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Expression of mRNA transcripts for members of the SACC families in purified WT 
and Stim1-/- microglia. Whole mouse brain extract was used as positive control for 
RT-PCR; 18srRNA was used as control for cDNA loading.
10. Comparisons of mitochondrial characteristics between WT and 
Stim1-/- microglia
Having observed the complete blockage of fluctuations in the local [Ca2+]micro-
domains in Stim1-/- microglia following treatment with either CCCP or rotenone, we set 
out to phenotypically characterize the mitochondria in both WT and Stim1-/-
microglia using transmission electron microscopy (TEM). To assess the changes in
the structural features of mitochondria from WT and Stim1-/- microglia, including 
the double layer membrane and cristae, had no discernible differences (Fig. 11A),
and total numbers of mitochondria were similar in each cell (Fig. 11B).
However, we tested the mRNA expression of each isoform of the tether 
proteins; (Mitofusin- and Miro-) using RT-PCR analysis, the levels of Mitofusin-1, 
Mitofusin-2, Miro-1 and Miro-2 genes are more increased in Stim1-/- microglia than 
WT cells (Fig. 11C). These data suggested that STIM1 may participate in the 
allocation of mitochondria.
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Figure 11. Comparisons of the structure and the total numbers of mitochondria 
of WT and Stim1-/- microglia using TEM. (A) TEM images of WT and Stim1-/-
microglia. The mitochondria are indicated in pale pink. N = nucleus; MT = 
mitochondria; G = Golgi apparatus; rER = rough endoplasmic reticulum; V = 
vacuole. Scale bars; 1000 nm (B) The total numbers of mitochondria per cell were 
counted in the plane of section containing the nucleus. (C) Expression of mRNA 
transcripts for members of the Mitofusin- and Miro- families in purified WT and 
Stim1-/- microglia. Whole mouse brain extract was used as a positive control for RT-
PCR; 18srRNA was used as loading control for cDNA.
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IV. DISCUSSION
Our key findings suggest that, while STIM1-mediated SOCE is certainly 
important in the regulation of global [Ca2+]i changes, STIM1 is also the foremost
regulator of the local [Ca2+]micro-domains in murine microglia. So, we claim that STIM1
orchestrates the Ca2+ signaling that modulates the immune function of murine 
microglia.
Our current study is largely divided into two parts. In the first part, we studied 
the global [Ca2+]i changes influenced by the immunological functions of microglia;
such as phagocytosis, cytokine secretion, chemotaxis (both in vitro and in vivo)
following LPS, UDP or ATP-stimulation using primary cultured WT and Stim1-/-
microglia from C57BL/6 strain mice and the brains of embryonic Stim1-/- mice.6 In 
the second part, we paid careful attention to the local Ca2+ movements in the cell 
periphery of microglia, since we had established that there were severe defects in 
their chemotactic activities in vitro and in vivo.
Initially, we evaluated the role of STIM1-mediated SOCE activation and Ca2+
release activated channel (CRAC) activation. STIM2 has less of an effect than 
STIM1 in T-cells.5,22 Michaelis et al. recently reported that Stim2-/- microglia 
displayed SOCE activation upon store depletion and nucleotide stimulation, in 
contrast to the complete absence of SOCE in Stim1-/- microglia.20 In spite of the 
presence of STIM2 (Fig. 1A, B), the western blot analyses and [Ca2+]i 
measurements demonstrated that STIM1 is the primary regulator of SOCE in 
microglia. STIM2 is a feedback regulator that stabilizes the [Ca2+]i via reduction of 
ER [Ca2+]-sensitive translocation to the plasma membrane.15 We did not detect 
significant changes in Stim2 mRNA (Fig. 1A) or STIM2 protein (Fig. 1B) in Stim1-
/- microglia, and the basal [Ca2+]i was lower in Stim1-/- microglia than in WT (Fig. 
1C, D). These result suggest that an increased interaction of STIM2 with Orai 
isotypes does not induce basal [Ca2+]i elevation. The current study suggests that 
STIM1 is the major regulator of SOCE-mediated Ca2+ influx and is the critical 
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determinant of the basal [Ca2+]i levels in microglia. A principal role for STIM1 in 
global [Ca2+]i changes was demonstrated in cells treated with LPS, which activates 
innate immune functions in microglia. Both basal phagocytosis (Fig. 2A, B) and 
secretion of the cytokines TNF-α and IL-6 (Fig. 2C, D) following LPS treatment, 
were reduced significantly in Stim1-/- microglia. These data are consistent with the 
established role of SOCE-mediated global [Ca2+]i, which changes during pro-
inflammatory activation of microglia.
Cell migration is coordinated by Ca2+ signaling, in part through local Ca2+
signaling in the leading cell edge.36 Previous reports have shown that STIM1
localize to podosomes,66 phagosomes,34 and cell-matrix adhesions at the front of 
migrating cells.36 Recent work have shown that receptor tyrosine kinase signaling
and phospholipase-C signaling are restricted to the front of migrating endothelial 
leader cells, which triggers local STIM1 activation, local Ca2+ pulses and local 
depletion of ER-Ca2+. These cascades orchestrate pulsatile retraction and adhesion 
of the leading cell front.36 Another study reported that STIM1 localization is 
juxtaposed to the ER and to phagosomes, which generate Ca2+ hotspots that boost 
phagocytosis.34
Our results are in agreement with the findings of these previous studies;
namely, that STIM1-regulated local Ca2+ influx to the leading focal adhesion micro-
domains influences for the functions mediated by local cytoskeletal rearrangement.
These include a reduction in UDP-induced rapid phagocytosis (Fig. 3F, G) and 
ATP-induced chemotaxis (Fig. 4C) in Stim1-/- microglia. UDP-induced 
phagocytosis is relatively fast, yet its capacity is comparably smaller, compared to
basal phagocytosis of opsonized beads. We demonstrated that phagocytosis is 
highly dependent on STIM1-mediated Ca2+ influx to local micro-domains after P2Y6
stimulation because UDP-induced phagocytosis became markedly impaired in 
Stim1-/- microglia. Similarly, time-dependent ATP-stimulated cell migration was 
essentially abolished in Stim1-/- microglia. This in vitro result was confirmed in the 
in vivo studies,53 which showed that cell migration to the injured site was severely 
impaired in Stim1-/- mice (Fig. 4D-F). Injured cells release nucleotides such as ATP, 
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which is a known chemotactic attractant and an activator of purinergic receptors 
such as P2X4 and P2Y12, involved in the rapid cell migration fundamental for 
microglial recruitment to the site of brain lesions.49,60 The defective chemotaxis of 
Stim1-/- microglia demonstrated clearly that STIM1 is an essential regulator of 
chemotaxis governed by local Ca2+ micro-domains. These data suggest that the 
contribution of STIM1 to local Ca2+ micro-domains is not negligible in comparison 
with the global [Ca2+]i changes. The immunocytochemistry of STIM1 and ORAI1
was compared between WT and Stim1-/- microglia, showing that the efficient and 
appropriate localization of ORAI1 following stimulation with either LPS or UDP 
requires STIM1 (Fig. 6). We surmise from our data that STIM1 produces in global 
[Ca2+]i changes and it also has a role in regulating local Ca
2+ micro-domains which 
are principally responsible for phagocytosis and cytoskeletal rearrangement during 
stimulus-induced cell movement.
In the migrating cell, a Ca2+ concentration gradient forms locally at certain 
regions of the cell.64 The research spotlight is now on the notion that ‘local Ca2+
signals’, ‘Ca2+ micro-domains’, or ‘local hot spots’ of high Ca2+ generated by the 
opening of Ca2+ channels in the cell periphery.37-39,67,68 A role for STIM1 in the
migration of various cells is being increasingly reported. Human STIM1 is locally 
activated in the migrating front HUVEC cells.36 Another study reported that Ca2+
influx mediated by ORAI1 and STIM1 may promote tumor metastasis, migration 
and invasion. This study also highlighted the interplay between STIM1 and turnover 
of focal adhesions, which is needed for migration.63 However, none of these reports 
suggested the direct requirement of STIM1 in migration, nor did they elucidate the 
detailed mechanism, nor did they focus on the coordination of Ca2+ signaling
through controlling [Ca2+]micro-domains.
Initially, we found the changes in the local [Ca2+]micro-domains in the cell periphery
of Stim1-/- microglia stimulated with 50 μM ATP (Fig. 7A, B) or 100 μM UDP, 
were noticeably higher than WT (Fig. 7B, D) in combined images(∑△F) analyzed 
by MetaMorph software. We measured not only the global change of [Ca2+]i in the 
single whole cell, but also the local [Ca2+]micro-domains of WT (Fig. 8A) and Stim1-/-
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microglia (Fig. 8B, 9A). When we tested the impact of an extracellular Ca2+-free
environment on Stim1-/- microglia (Fig. 9B), the local [Ca2+]micro-domains appeared
slightly reduced, yet huge changes of in the local [Ca2+]micro-domains still occurred. 
These data hinted that the primary source of the fluctuating local [Ca2+]micro-domains  
derives from Ca2+ released by intracellular organelles. We confirmed this, since 
both CCCP (Fig. 9D) and rotenone (Fig. 9E) greatly disturbed the fluctuations in the 
local [Ca2+]micro-domains of Stim1-/- microglia. In contrast, the IP3R inhibitor, 2-APB, 
had no such effect (Fig. 9C). These data implied that the fluctuating local [Ca2+]micro-
domains in Stim1-/- microglia is generated by mitochondria but not the ER.
Interestingly, the transcript levels of Mcu (mitochondrial Ca2+ uniporter), Ncx1
(Na+/Ca2+ exchanger) and Letm1 (Ca2+/H+ antiporter) are up-regulated in Stim1-/-
microglia, but Vdac- (voltage-dependent anion channel) is not (Fig. 9H). At present, 
we cannot conclude that the increased expression of two mitochondrial Ca2+ influx 
proteins is responsible for the fluctuating [Ca2+]micro-domains, so the testing of specific 
inhibitors against both proteins is warranted in future experiments. In addition, we 
cannot conclude that their altered expression is caused by the absence of STIM1, 
including Mitofusin- and Miro- families, the tether genes (Fig. 11C). Mitofusin-2, 
the protein which tethers mitochondria to the ER-membrane, is known to be a 
necessary factor for STIM1 translocation into junction between the ER and the 
plasma membrane in MEK cells,44 In spite of this, the molecular 
mechanism/physical detail of this interaction has not been revealed. Our finding that 
the allocation of mitochondrial tether genes is affected by STIM1, provides further
evidence for the interaction between STIM1 and mitochondria. Moreover, although 
the detailed mechanism remains vague, inhibition of ORAI1 also reduced the 
fluctuations in the [Ca2+]micro-domains, which strongly supports the previous reports 
that mitochondrial Ca2+ buffering capacity is influenced by SOCE-mediated Ca2+
influx. On the other hand, TEM results showed that the structure of mitochondria is 
indistinguishable between WT and Stim1-/- microglia (Fig. 11A), and that total 
numbers of mitochondria were same in both groups (Fig. 11B). The exact cause of 
the functioning of mitochondria in Stim1-/- microglia will need to be investigated by
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further experiments.
These results comprehensively demonstrate that STIM1 is a critical controller 
of the local [Ca2+]micro-domains, not only through regulating local SOCE pores, but also 
through coordinating the mitochondrial Ca2+ buffering capacity in the micro-
domains of the cell periphery
The phenomenon of fluctuating [Ca2+]micro-domains in Stim1-/- microglia seems 
to have been veiled so far, due to the general [Ca2+]i monitoring methods in use, 
which only monitor the [Ca2+] change throughout the whole cell. Notably, we could 
capture this local fluctuation in the [Ca2+]micro-domains in Stim1-/- microglia using two 
reliable methods; the measurement of the [Ca2+] through drawing small ROIs only 
in local regions of cells, and the summation of these [Ca2+] changes during a period 
of stable [Ca2+]i in Stim1-/- microglia. Of course, although the extremely thin layer 
of the peripheral region in microglia seems to provide the ideal vantage point to 
monitor the [Ca2+]micro-domains, we have reasons nonetheless to expect that this 
fluctuating [Ca2+]micro-domains caused by depletion of STIM1 will be seen in many 
other cell types.
Besides the confirmation that STIM1-mediated SOCE is centrally important in 
the regulation of global [Ca2+]i changes in microglia, the distinctiveness of our study 
lies the novel finding of hitherto unnoticed roles of STIM1 in the regulation of local 
Ca2+ micro-domains in physiological situations. The fluctuating local [Ca2+]micro-
domains and severe migration defects in Stim1-/- microglia might have a causal
relationship, which would suggest that STIM1 is required to stabilize and control
the Ca2+ signal at the [Ca2+]micro-domains in the cell periphery, allowing coordinated
movements in murine microglia. Although we did not elucidate the exact molecular 
defects in the mitochondrial Ca2+ buffering capacity in cells lacking STIM1, our 
data clearly shed new light on the regulatory function of STIM1 in the local Ca2+
signal produced at micro-domains. STIM1 orchestrates this signal, not only via
local SOCE channels, but also by coordinating the Ca2+ buffering capacity of 
mitochondria near to SOCE pores.
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V. CONCLUSION
In the present study, we have focused on the changes in both global [Ca2+]i
by SOCE, and local [Ca2+]micro-domains, which are related to chronic and acute 
movements, respectively, using primary cultured WT and Stim1-/- microglia. Our 
current study examined the in vitro and in vivo effects of STIM1-modulated SOCE 
in pathogen- or purinergic-mediated immunological functions using microglia from 
Stim1-/- mice. STIM1 is the primary determinant of SOCE-mediated Ca2+ influx and 
the main regulator of basal [Ca2+]i levels in murine microglia. STIM1 is also 
important for innate immune function such as phagocytosis and cytokine release in 
LPS-stimulated microglia. We found a reduction of chemotaxis in vitro and in vivo, 
which prompted us to visualize the changes in the local [Ca2+]micro-domains in the cell 
periphery following UDP-stimulation in LPS-activated Stim1-/- microglia.
Most unexpectedly, Stim1-/- microglia showed massive changes in the local 
[Ca2+]micro-domains compared to WT; so we established that the sources of the 
fluctuating local [Ca2+]micro-domains derive from both inside and outside the cell. 
Application of the Ex-Orai1 antibody and SKF-96536 (a SOC inhibitor), we 
concluded that the fluctuating local [Ca2+]micro-domains in Stim1-/- microglia are 
partially caused by surface ORAI1. Above all, we confirmed that the main cause of 
the fluctuation in the local [Ca2+]micro-domains is mediated by mitochondria. That is, 
STIM1 inhibits the fluctuating Ca2+ flickers occurred via mitochondria which are 
capably manage the stability of local Ca2+ signals to react immediately upon acute 
movements in murine microglia.
Taken together, these in vitro and in vivo results demonstrate that STIM1-
mediated SOCE is the decisive factor in the regulation of global [Ca2+]i changes, 
and is crucial for the regulation of local [Ca2+]micro-domains in murine microglia. We 
conclude that STIM1 orchestrates the physiological Ca2+ signaling that modulates
the immune function of murine microglia.  
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ABSTRACT (in Korean)
미세아교세포에서 STIM1 에 의해 매개되는
칼슘신호 전달기전을 통한 면역기능의 조절
<지도교수 김 주 영>
연세대학교 대학원 의과학과
임 혜 민
진핵세포에서 칼슘이온의 조절은 세포의 삶과 죽음을 결정지을 수 있는
중요한 세포 내 신호전달물질이기 때문에 이에 대한 연구가 중요하다. 활성화된
면역세포의 분화에는 항원 자극 이후 지속적으로 높은 농도의 세포질 내 칼슘이
면역세포의 증식, 사이토카인 분비, 식세포 작용 등 매우 중요하다고 알려져 있다.
다양한 종류의 면역세포들을 이용하여 SOCE 를 통한 칼슘 유입이 미치는 면역세포의
기능에 대한 연구가 활발히 진행되는 추세이지만, 면역세포마다 SOCE 가 미치는
영향력이 조금씩 다르기 때문에 각 면역세포에서의 정확한 이해가 필요한 실정이다. 
STIM1 은 세포 내 칼슘 저장고인 소포체에서 칼슘 결핍 신호에 의해 세포막의 ORAI1 
과 기능적 단위를 이루어 SOCE (Store-Operated Ca2+ Entry) 를 통해서 세포 밖의
칼슘을 세포질 내로 유입시키는 SOC 의 구성 단백이다. 세포질 내로 유입된 칼슘은
칼슘농도 의존적 인산화·탈인산화 단백 및 NFAT 을 비롯한 다양한 칼슘의존적
전산인자들을 통해 유전자 발현의 변화, 세포 성장과 같은 long-term cellular 
response 에 필요한 칼슘신호를 유발하는데 매우 중요한 역할을 한다. 한편, 세포막
수용체 자극으로 국소적으로 발생한 칼슘신호는 신속하게 국소적 탈부착 및 변형과
관련된 골격단백들 및 인산화단백의 조절을 위해서 필요하며, 세포의 신속한
이동이나 식세포작용에 중요한 것으로 알려져 있다.
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본 연구에서는 RIKEN 의 Kurosaki 연구진으로부터 분양 받은 C57BL/6 계통의
Stim1 유전자가 소실된 마우스를 이용하였다. Stim1 소실은 근병증을 유도하여 출산
직후, 치사(致死)하므로 17일 경의 배아의 뇌를 일차배양 하여 얻은 미세아교세포를
실험에 적용하였다. LPS 처리에 의해 활성화 된 정상 미세아교세포는 감염원을
제거하기 위해 Pro-inflammatory 인자들을 분비하게 되는데, Stim1 소실 미세아교
세포에서는 TNF-α와 IL-6 의 사이토카인 분비 감소, 식세포 작용의 저하 및 single 
live cell [Ca2+]i imaging 기법을 이용하여 SOCE 를 통한 칼슘 유입이 거의
이루어지지 않음을 확인하였다. 또한, FACS 를 이용한 UDP 에 의한 식세포 작용 및
in vitro 상에서 chemotaxis chamber 를 이용한 ATP 에 의한 세포이동 능력이 저하
되어 있음을 확인하였다. 교배시킨 Stim1 소실 hetero 암컷 마우스를 호흡 마취
시켜 배아의 한쪽 뇌에 LPS 를 microinjection 한 뒤, 24시간 후에 정상 및 Stim1
소실 배아의 뇌 조직에 활성화 된 미세아교세포의 몰려든 수를 비교한 결과, in 
vivo 상에서도 세포이동 능력은 저하 되었다. 위의 본 연구 결과들을 통해서,
미세아교세포에서 STIM1 단백에 의해 매개되는 칼슘신호 전달기전을 통해
면역기능이 조절된다는 사실을 확인하였다.
한편, STIM1 과 ORAI1 의 분자적 메커니즘을 살펴보고자, TG, UDP, LPS 등
자극을 준 뒤, 세포 표면에 발현하는 ORAI1 의 움직임을 면역염색법을 통해
관찰하였다. TG 처리시, Stim1 소실 미세아교세포에서도 cell periphery 끝부분까지
세포막 ORAI1 발현이 약간 증가했지만, 세포 밖의 칼슘을 유입시키는 기능적 단위를
이루기 위해서는 반드시 STIM1 이 필요하다는 사실을 정상 미세아교세포의 확장된
ORAI1 의 cluster size 를 통해 확인했다. 또한, UDP 자극에 따른 세포막 ORAI1 이
cell periphery 에 발현하거나, 혹은 LPS 처리에 의해 핵 주변부에 발현하기
위해서는 모두 STIM1 이 필요하다는 사실을 확인 하였다. 
이동하는 세포의 periphery 에는‘calcium flicker’라고 불리는 고농도의
칼슘이 micro-domains 에 국소적으로 존재하다 사라지는 이 부위로 인해서 세포가
방향성 있게 움직이는 등 periphery 의 국소적 칼슘신호와 세포 움직임의 연관성이
보고 된 바 있다. 세포 이동 능력이 저하되어 있는 Stim1 소실 미세아교세포의
peripheral 부위에서 칼슘신호의 변동 정도를 확인한 결과, 뜻밖에도, Stim1 소실
군에서 cell periphery 에서 칼슘농도의 변동이 매우 큰 현상이 관찰되었고, 그
cell periphery 의 국소적 부위와 단일세포 전체의 칼슘 움직임과는 무관함을
발견하였다. 이러한 국소적 칼슘농도변화 (이하 칼슘요동)의 원인을 규명하기
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위하여 세포 밖 칼슘농도가 없는 조건에서 관찰한 결과, 칼슘요동은 폭이 약간
감소하였지만 여전히 일어났다. 또한 2-APB 처리로 소포체의 IP3R 를 차단하였을
때는 칼슘요동현상이 억제되지 않은 반면, CCCP 나 Rotenone 을 각각 처리하여
미토콘드리아의 막전위를 억제하면, 칼슘요동현상이 억제되는 것이 확인되었다. 
위의 결과를 통해서 STIM1 의 부재 시, 미토콘드리아의 Ca2+ micro-domains 의
칼슘농도 조절능력에 결핍이 발생하는 것을 확인하였다. 또한, cell periphery 
에서의 칼슘요동현상이 미처 이동하지 못한 세포막 ORAI1 이 기여하는지를
확인하고자, Extracellular-Orai1 항체 및 SKF-96365 약물을 이용하여 SOC 를
봉쇄하였고, 칼슘요동현상이 저해되는 것이 모두 확인 되었다. 반면, SACC 채널의
억제제인 Streptomycin 을 처리 하였을 때는 저해되지 않았다. 이러한 현상은
미토콘드리아의 국소적 칼슘농도조절에 SOCE 를 통한 칼슘유입에 영향을 받는다는
알려진 사실과 연관하여 볼 때, STIM1 부재 시 나타나는 칼슘요동이 미토콘드리아의
국소적 칼슘농도 조절능력의 결함에 의한 결과임을 다시 한번 확인시켜 주었다.
결론적으로 본 연구는 미세아교세포의 면역반응을 매개하는 칼슘신호에
전반적으로 STIM1 이 관련되어 있음을 규명하였다. 그 중 특히 신속한 움직임과
연관된 국소적 칼슘신호조절에 STIM1 이 매우 중요한 조절자임을 규명하였으며, 그
관련기전으로 세포 내 국소적 칼슘농도를 조절하고 있는 미토콘드리아의
칼슘유·출입능이 STIM1 에 의해 조절됨을 최초로 제안하는 바이다.
핵심되는 말: STIM1, SOCE, 칼슘 유입, 미세아교세포, 면역기능, 식세포 작용, 세포
이동, 국소적인 칼슘 움직임, 칼슘요동현상, 미토콘드리아
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